Evidence map›Paper›PMID 41163050›Full record

ArticleCell & bioscience2025

IgD in nucleus of pro-B cells promotes pro-B cells proliferation by regulating E2F3 expression.

Yixiao Zhang, Yanqi Hou, Meng Yu, Xin Zhang, Shenghua Zhang, Zhu Zhu, Weiyan Xu, Jing Huang, Xiaoyan Qiu

Abstract read
In one paragraph

Article in Cell & bioscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yixiao Zhang *Department of Immunology, School of Basic Medical Sciences, and NHC Key Laboratory of Medical Immunology, Peking University, Beijing, 100191, People's Republic of China.
Yanqi Hou *Department of Immunology, School of Basic Medical Sciences, and NHC Key Laboratory of Medical Immunology, Peking University, Beijing, 100191, People's Republic of China.
Meng YuDepartment of Immunology, School of Basic Medical Sciences, and NHC Key Laboratory of Medical Immunology, Peking University, Beijing, 100191, People's Republic of China.
Xin ZhangInstitute of Systems Biomedicine, School of Basic Medical Sciences, Peking University, Beijing, 100191, People's Republic of China.
Shenghua ZhangDepartment of Immunology, School of Basic Medical Sciences, and NHC Key Laboratory of Medical Immunology, Peking University, Beijing, 100191, People's Republic of China.
Zhu ZhuDepartment of Immunology, School of Basic Medical Sciences, and NHC Key Laboratory of Medical Immunology, Peking University, Beijing, 100191, People's Republic of China.
Weiyan XuDepartment of Immunology, School of Basic Medical Sciences, and NHC Key Laboratory of Medical Immunology, Peking University, Beijing, 100191, People's Republic of China.
Jing HuangDepartment of Immunology, School of Basic Medical Sciences, and NHC Key Laboratory of Medical Immunology, Peking University, Beijing, 100191, People's Republic of China. huangjing82@bjmu.edu.cn.
Xiaoyan QiuDepartment of Immunology, School of Basic Medical Sciences, and NHC Key Laboratory of Medical Immunology, Peking University, Beijing, 100191, People's Republic of China. qiuxy@bjmu.edu.cn.

Funding

National Natural Science Foundation of China 82030044 and 82341227National Natural Science Foundation of China 82371733,82171806
6 · The paper itself

Abstract

backgroundImmunoglobulin D (IgD) has historically been considered as a surface marker of mature B cell with its specific function being undefined. Until now, no evidence had been presented to suggest that IgD is also expressed in pro-B cells. This study was designed to elucidate the significance for IgD in early B cell development.

resultsHere we developed a mouse model with a targeted deletion of IgD, and assessed the production of the IgM, IgG and IgA, as well as the generation of the antigen specific antibodies. The findings indicated no significant differences in these Ig levels between wild-type and IgD-deficient mice. However, we observed a notable reduction in the number of mature B cells, which led us to the surprising discovery that this decrease in B cell count begins at the pro-B cell stage. More significantly, we identified that IgD, in its intact tetrameric structure, is expressed in the nucleus of pro-B cells. Functionally, IgD appears to promote the proliferation of pro-B cells. Mechanistically, IgD exhibits a transcription factor-like activity, and directly binds to the promoter region of E2f3, a pro-proliferative transcription factor to drive the expression of E2f3, thereby promoting pro-B cells proliferation.

conclusionsTaken together, this novel insight into the physiological significance of IgD in B cell development has important implications for our understanding of immune system function.

Indexed as

E2f3IgDPro-B cellProliferation

Identifiers

PMID41163050
PMCPMC12573911

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.